News and Events
In October 2016, the U.S. Food and Drug Administration approved Carnexiv™ (carbamazepine) injection as a short-term replacement therapy for oral carbamazepine formulations in adults with certain seizure types when oral administration is temporarily not feasible.
“I’m driven to discover better ways to match drugs to [each] individual,” said Professor Pamala Jacobson.
A new formulation for a University of Minnesota-developed drug targeted at rare disorders is under development, with the potential to help a small number of Americans each year.
James Cloyd has been selected to receive the Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics by the Pediatric Pharmacy Advocacy Group.
Ling Li has been selected as the recipient of the 2015-2016 Fesler-Lampert Chair in Aging Studies by the Center on Aging. This award comes with $40,000 funds to support aging-related research and activities.